Literature DB >> 30775651

p53: Multiple Facets of a Rubik's Cube.

Yun Zhang1, Guillermina Lozano1.   

Abstract

The p53 tumor suppressor has been studied for decades, and still there are many questions left unanswered. In this review, we first describe the current understanding of the wild-type p53 functions that determine cell survival or death, and regulation of the protein, with a particular focus on the negative regulators, the murine double minute family of proteins. We also summarize tissue-, stress-, and age-specific p53 activities and the potential underlying mechanisms. Among all p53 gene alterations identified in human cancers, p53 missense mutations predominate, suggesting an inherent biological advantage. Numerous gain-of-function activities of mutant p53 in different model systems and contexts have been identified. The emerging theme is that mutant p53, which retains a potent transcriptional activation domain, also retains the ability to modify gene transcription, albeit indirectly. Lastly, because mutant p53 stability is necessary for its gain of function, we summarize the mechanisms through which mutant p53 is specifically stabilized. A deeper understanding of the multiple pathways that impinge upon wild-type and mutant p53 activities and how these, in turn, regulate cell behavior will help identify vulnerabilities and therapeutic opportunities.

Entities:  

Keywords:  age specificity; gain of function; missense mutation; p53 stabilization; stress specificity; tissue specificity

Year:  2016        PMID: 30775651      PMCID: PMC6374046          DOI: 10.1146/annurev-cancerbio-050216-121926

Source DB:  PubMed          Journal:  Annu Rev Cancer Biol        ISSN: 2472-3428


  9 in total

1.  Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Authors:  Elena Papaleo
Journal:  Methods Mol Biol       Date:  2021

2.  Network Topologies That Can Achieve Dual Function of Adaptation and Noise Attenuation.

Authors:  Lingxia Qiao; Wei Zhao; Chao Tang; Qing Nie; Lei Zhang
Journal:  Cell Syst       Date:  2019-09-18       Impact factor: 10.304

3.  Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP53.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-14       Impact factor: 11.205

Review 4.  p53 and Tumor Suppression: It Takes a Network.

Authors:  Anthony M Boutelle; Laura D Attardi
Journal:  Trends Cell Biol       Date:  2021-01-28       Impact factor: 20.808

Review 5.  Should mutant TP53 be targeted for cancer therapy?

Authors:  Andreas Strasser; Gemma L Kelly; Zilu Wang
Journal:  Cell Death Differ       Date:  2022-03-24       Impact factor: 12.067

6.  Taxifolin and Lucidin as Potential E6 Protein Inhibitors: p53 Function Re-Establishment and Apoptosis Induction in Cervical Cancer Cells.

Authors:  Diana Gomes; Shivani Yaduvanshi; Samuel Silvestre; Ana Paula Duarte; Adriana O Santos; Christiane P Soares; Veerendra Kumar; Luís Passarinha; Ângela Sousa
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

7.  Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women.

Authors:  Matteo Floris; Giovanna Pira; Paolo Castiglia; Maria Laura Idda; Maristella Steri; Maria Rosaria De Miglio; Andrea Piana; Andrea Cossu; Antonio Azara; Caterina Arru; Giovanna Deiana; Carlo Putzu; Valeria Sanna; Ciriaco Carru; Antonello Serra; Marco Bisail; Maria Rosaria Muroni
Journal:  Oncol Lett       Date:  2022-08-08       Impact factor: 3.111

Review 8.  A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer.

Authors:  Yuqing Xiong; Yun Zhang; Shunbin Xiong; Abie E Williams-Villalobo
Journal:  Biology (Basel)       Date:  2020-09-11

9.  p53 induces a survival transcriptional response after nucleolar stress.

Authors:  Han Liao; Anushri Gaur; Claire Mauvais; Catherine Denicourt
Journal:  Mol Biol Cell       Date:  2021-07-28       Impact factor: 4.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.